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© 2009 The Japan Society of Histochemistry and Cy- Recent neuropathological studies have shown that Fluoro-Jade C (FJC), an anionic fluores-
cent dye, is a good marker of degenerating neurons. However, those studies have mostly
examined acute rather than chronic models of neurodegeneration. We therefore compared
FJC staining using the intrastriatal 6-hydroxydopamine (6-OHDA)-injected rat as an acute
model and the zitter rat as a chronic model, as both show dopaminergic (DA) neurodegen-
eration. In the 6-OHDA-injected rat, FJC-positive neurons were found in the substantia nigra
pars compacta (SNc) before the loss of tyrosine hydroxylase (TH)-positive DA neurons. In
the zitter rat, FJC-labeled fibers were first detected at 1 month old (1M) and were consider-
ably increased in the striatum at 4M, whereas FJC-labeled cell bodies were found at 4M, but
not at 1M in the SNc. Furthermore, FJC-labeled neurons of the zitter rat showed TH-
immunoreactivity in fibers, but little in cell bodies, while those from the 6-OHDA-injected rat
showed TH-immunoreactivity even in the cell bodies. These results demonstrate that FJC is
a useful tool for detecting chronically degenerating neurons, and suggest that intracellular
substances bound to FJC may accumulate in the cell bodies from fibers at a slower rate in
the chronic model than in the acute model.
Key words: Fluoro-Jade C, zitter rat, 6-OHDA, dopaminergic neurons, chronic neurodegenerative
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I. Introduction
One of the central questions in the neuropathology of
neurodegenerative disease is how to detect differences in the
vulnerability of neuronal populations to cell death. In par-
ticular, identifying the onset of this irreversible process is
crucial to the development of therapeutic interventions
for neurodegenerative disease. One putative marker of de-
generating cells that is increasingly being used for studies
of neuronal degeneration in the brain is Fluoro-Jade C (FJC)
[20]. FJC, a fluorescent anionic dye, shows greater morpho-
logical detail of degenerating neurons than its predecessors,
Fluoro-Jade and Fluoro-Jade B [18, 19]. Furthermore, the
dye is reportedly compatible with several histological proc-
essing and staining protocols. Recent studies using double
labeling with FJC staining and immunofluorescence (IF)
have shown the degenerating cell types [1, 3, 20, 25]. Con-
cerning the procedure for double labeling, Schmued et al.
(2005) performed IF first followed by FJC staining (IF-FJC)
to detect degenerating neurons in the cerebral cortex
and hippocampus of the kainic acid (KA)-treated rat [20].
Thereafter, many researchers using the Schmued method
of IF-FJC have investigated several neurodegeneration
models, including models of Parkinson’s disease (PD).
However, the double-labeling method has varied consider-
ably among researchers. Even in the same laboratory, Wang
et al. (2008) performed IF-FJC, whereas Chen et al. (2008)
performed the converse procedure with FJC staining fol-
lowed by IF (FJC-IF) [3, 25].
Evaluation of previous methods has shown problems
involving three processes: 1) procedure; 2) photobleaching;
and 3) pretreatment. In terms of procedure, whether FJC
staining or IF should be performed first for optimal results
remains unclear. With photobleaching, although an acidicEhara and Ueda 172
glycerol medium is used for double labeling, little is known
about the stability of either staining in the medium under
photo-irradiation. As for pretreatment, pretreatment with
potassium permanganate results in high-contrast FJC
staining, but is known to decrease the intensity of IF. The
present study initially investigated the optimal double-
labeling method using the KA-treated rat model of acute
neurodegeneration in the hippocampus and cerebral cortex
[18, 20].
Next, to compare acute and chronic neurodegeneration,
we used two different animal models for PD: the 6-hydroxy-
dopamine (6-OHDA)-injected rat as a model of acute neu-
ronal degeneration [5, 14, 17] and the zitter mutant rat as a
model of chronic neuronal degeneration. Intrastriatal injec-
tion of 6-OHDA results in the death of dopaminergic (DA)
neurons in the ipsilateral substantia nigra pars compacta
(SNc), which progresses over the first few weeks after injec-
tion. The zitter rat is an autosomal recessive spontaneous
mutant with an 8-bp deletion at a splice donor site of the
attractin gene [13], and displays progressive and selective
nigrostriatal DA neuron death [22]. In the zitter rat, the
number of tyrosine hydroxylase (TH)-positive neurons
resembles that of the Sprague-Dawley (SD) rat until 1 month
old (1M), but greatly decreases from 2M to 12M [15, 23].
However, little is known about when and where the DA
neurons are first damaged and how degeneration proceeds
in the nigrostriatal pathway of this mutant rat. To address
these issues, FJC may be useful to investigate the spatio-
temporal distribution of damaged neurons in the zitter rat.
In the present study, to investigate the utility of FJC as
a marker of degenerating neurons in the acute or chronic
degenerative model, we first examined the optimal double-
labeling method with FJC and IF, and then demonstrated
FJC staining using SD rats 3 days after 6-OHDA injection
or zitter rats. In the zitter rat, staining was observed at time-
points of 1M, 4M, and 12M with a focus on the dynamic
time-course patterns of degenerating neurons. Furthermore,
double-labeling studies were carried out in brain sections
to analyze the properties of dying DA neurons by combing
FJC staining with immunofluorescence to neuron-specific
nuclear antigen (NeuN), a neuronal marker), glial fibrillary
acidic protein (GFAP), an astrocyte marker, and tyrosine
hydroxylase (TH), a DA neuronal marker.
II. Materials and Methods
Animals
Male homozygous zitter mutant (zi/zi) rats and male
age-matched SD rats at ages of 1M, 4M, and 12M were used
in this study. Animals were provided ad libitum access to
food and water, and maintained on a 12-hr light/12-hr dark
cycle. Rats were handled in accordance with the National In-
stitutes of Health “Guide for the care and use of laboratory
animals” and the experimental protocol was approved by the
Animal Research Committees of Dokkyo Medical Universi-
ty School of Medicine.
Pharmacological treatment
KA (10 mg/kg body weight; Sigma, St. Louis, MO,
USA) dissolved in physiological saline was injected intra-
peritoneally into SD rats, then tissues were examined 2
days after injection [20]. Rats in the control group were in-
jected with solvent alone.
The 6-OHDA (6 mg/ml; Sigma, St. Louis, MO, USA)
was dissolved in saline containing 0.2 mg/ml ascorbic acid.
Rats were anaesthetized using a mixture of ketamine hydro-
chloride and xylazine, and received a single injection of 24
µg (4 µl) of 6-OHDA into the right striatum. The toxin was
injected stereotaxically through a 30-gauge cannula fitted to
a microsyringe at a rate of 1 µl/min. The cannula was slowly
withdrawn 3 min after the end of infusion. Stereotaxic coor-
dinates were taken from an atlas [16] and were the following
distances from the bregma: A, 0.6 mm; L, 2.5 mm; and V,
5.0 mm. Tissues were examined 3 days after lesion creation.
All rats were anaesthetized with pentobarbital and
perfused transcardially with 0.9% saline followed by 4%
paraformaldehyde and 0.2% picric acid in 0.1 M phosphate
buffer (PB) (pH 7.4). The brains were immediately removed,
then postfixed with the same fixative for 2 days at 4°C,
and cryoprotected for an additional 2 days by immersion in
0.1 M PB containing 30% sucrose at 4°C. After that, brain
samples were cut into serial sections of 30 µm thickness
using a cryostat.
Immunohistochemistry
Immunolabeling with a mouse anti-tyrosine hydroxy-
lase (TH) antibody (a marker of DA neurons) was performed
using the avidin-biotin-peroxidase technique (Vectastain
ABC kit, Vector Laboratories, Burlingame, CA) according
to a previous study [22]. Free-floating sections were
quenched for endogenous peroxidase activity by treating
them with 1% H2O2 in phosphate-buffered saline (PBS) for
1 hr at room temperature (RT), blocked for 1 hr at RT in
1.5% normal horse serum and PBS containing 0.3% Triton
X-100 (0.3% TPBS; Immunostar, Hudson, WI, USA), and
then incubated with a mouse anti-TH antibody (1:5000
diluted in TPBS) for 3 days at 4°C. Sections were placed
in an appropriate biotinylated secondary antibody diluted
in TPBS for 2 hr at RT followed by incubation with avidin-
biotin-peroxidase complex (Vector Laboratories) for 2 hr at
RT. Immunoreactivities were visualized using 0.2 mg/ml
3-3-diaminobenzidine tetrahydrochloride (DAB; Dojindo,
Kumamoto, Japan) and 0.006% H2O2 at RT. The sections
were then mounted on gelatin-coated slides, dehydrated
through graded concentrations of ethanol, cleared in xylene,
and coverslipped with Entellan New (Merck KGaA,
Darmstadt, Germany).
FJC staining
FJC, a polyanionic fluorescein derivative that can sen-
sitively and selectively bind to degenerative neurons [20],
was applied to examine dynamic time-course changes of
dying neurons in brains from the above animal models.
To visualize degenerative neurons, brain sections wereFluoro-Jade C in Neurodegeneration Models 173
mounted on gelatin-coated slides, air-dried, and subjected to
FJC staining. The slides were first immersed in a solution
containing 1% NaOH in 80% ethanol for 5 min. They were
rinsed for 2 min in 70% ethanol and for 2 min in distilled
water, then incubated in 0.06% potassium permanganate
solution for 10 min. Following a water rinse for 2 min,
slides were transferred to the FJC staining solution and
stained for 10 min. The proper dilution was accomplished by
first making a 0.01% stock solution of FJC dye (Chemicon,
Temecula, CA, USA) in distilled water and then adding
1 ml of the stock solution to 99 ml of 0.1% acetic acid.
Slides were washed three times each for 1 min and then air-
dried on a slide warmer at 50°C for 30 min. After clearing
in xylene and coverslipping with Entellan New, sections
were examined under an epifluorescence microscope
(BX51; Olympus, Tokyo, Japan). The fluorescein/FITC fil-
ter system was used for visualizing FJC staining and images
were captured for demonstration.
Double labeling with FJC and immunofluorescence
Double-labeling experiments were performed to con-
firm neuronal properties of FJC-positive cells in the sections
by combining IF to NeuN (a neuronal cell marker), TH (a
DA neuron marker), or GFAP (an astrocytic cell marker)
antisera. We used three different procedures: FJC-IF; FJC-
NaBH4-IF; and IF-FJC.
FJC-IF
Sections were first treated as for single FJC staining,
and then IF staining was performed. Sections were washed
in 0.1% TPBS, blocked for 1 hr in 0.1% TPBS containing
1.5% normal goat serum, washed in 0.1% TPBS, and incu-
bated in mouse anti-NeuN (1:500 dilution; Chemicon, CA,
USA) overnight at 4°C. After washing, sections were incu-
bated with Alexa568 conjugated goat anti-mouse IgG (1:500
dilution; Molecular Probes, Eugene, OR, USA) for 1 hr at
RT, washed in PBS and coverslipped in acidic mount media
(pH 4.5) containing 0.1% acetic acid and 80% glycerin.
FJC-NaBH4-IF
Sodium borohydride (NaBH4) has been suggested to
change fixative-induced double-bonded protein crosslinking
into single bonds, to reduce non-specific binding of anti-
bodies to sections, and thus to allow partial restoration of
the tertiary structures of antigens [8, 11, 26]. Pretreatment
of sections with NaBH4 appears to activate immunoreac-
tivity. We therefore applied NaBH4 treatment after FJC
staining. After single FJC staining, sections were incubated
in 0.1% sodium borohydride for 2 min followed by the
aforementioned IF staining.
IF-FJC
Sections were blocked in 0.1% TPBS containing 1.5%
normal goat serum and incubated in mouse anti-NeuN, rab-
bit anti-GFAP (1:2000 dilution, Sigma-Aldrich, St. Louis,
MO, USA), or mouse anti-TH (1:1000 dilution) antisera in
0.1% TPBS overnight at 4°C. Subsequently, sections were
rinsed in PBS, and incubated with Alexa568-conjugated
goat anti-mouse IgG for 1 hr at 37°C. After washing, sec-
tions were mounted on gelatin-coated slides, dried for 30
min at 50°C, and subjected to FJC staining. They were
rinsed for 5 min in distilled water, then incubated in 0.06%
potassium permanganate solution for 2–10 min. Following a
2-min water rinse, slides were transferred to the FJC staining
solution and stained for 10 min. The slides were washed and
then coverslipped in acidic mount media and examined
under an epifluorescence microscope. The photo-irradiation
was performed for 0, 3, 5, and 10 min.
Data analysis
Images were captured with an Olympus DP72 system
and processed using DP2-BSW software (Olympus) and
Adobe Photoshop version 6.0 software (Adobe Systems, San
Jose, CA, USA). These images were recorded under the
same imaging conditions throughout the same analysis. In-
tensity of fluorescence was measured and quantified using
Image J software (National Institutes of Health, Bethesda,
MD, USA) Intensity was calculated and expressed as the
average pixel intensity of the region of interest (ROI) sub-
tracted from the value of the background. For each ex-
periment, fluorescence was calculated from at least three
different ROIs. These values were averaged and divided
into five categories ranging from background intensity to
highest intensity (categories: –; +; ++; +++; ++++).
III. Results
Analysis of the optimal method to detect double labeling with 
FJC and IF
The pattern of FJC staining resulting from KA expo-
sure was consistent with a previous report [20]. Cell bodies
and processes of most FJC-positive cells were bright green
and exhibited neuronal profiles. These cells were extensive-
ly distributed in the cerebral cortex (layer V) and hippocam-
pus (CA3) (Fig. 1A, C). Little staining was found in the
control tissues (Fig. 1B, D).
In these cortical samples, to determine the optimal
method of double labeling with FJC and IF using NeuN
antibody as a neuronal marker and Alexa568-conjugated
secondary antibody, we investigated three processes. These
were the FJC/IF procedure, photobleaching time, and potas-
sium permanganate pretreatment time. The results are sum-
marized in Tables 1–3. First, we examined three procedures:
FJC-IF; FJC-NaBH4-IF; and IF-FJC (Table 1). FJC-IF
caused low intensity of FJC staining and little intensity of IF
staining. Even when slides were pretreated with NaBH4 pri-
or to IF in order to increase the intensity of IF (FJC-NaBH4-
IF), intensities of both FJC and IF staining were low. In con-
trast, IF-FJC showed high intensity of both types of staining.
In particular, FJC staining was found not only in specific
cells, but also in background tissue. Consequently, IF-FJC
was the procedure that yielded the best results from double
labeling with FJC and IF.
Next, we checked the duration of stability of both sig-Ehara and Ueda 174
nals on sections coverslipped in acidic mount media under
photo-irradiation. Intensity of FJC staining was stable for at
least 10 min, whereas that of IF staining decreased with time
and had diminished by 10 min (Table 2). Considering that a
few minutes was required to observe the sections, the next
experiment was treated after photo-irradiation for 3 min.
Finally, to detect high-contrast double labeling, we
evaluated pretreatment time (2, 5, 7, and 10 min) with potas-
sium permanganate. FJC background gradually decreased
with the length of pretreatment. Pretreatment for 2 min
yielded intense labeling with high background activity. Pre-
treatment for 5 or 7 min resulted in high to moderate intensi-
ty and low background activity for both stainings (Table 3),
while pretreatment for 10 min resulted in very clear identifi-
cation of FJC staining cells within low background but di-
minished IF staining. We therefore used 5-min potassium
permanganate pretreatment in the following experiments.
FJC staining in an acute PD model
After intrastriatal 6-OHDA injection, substantial DA
fiber loss was seen in the striatum as well as neuronal loss
in the SN. Progression of DA degeneration over time on the
injected side resembled that described in previous reports
[5, 14, 17]. In the SN at day 3 after 6-OHDA injection, some
FJC-positive cell bodies and processes with neuronal pro-
files were clearly visualized on the ipsilateral side, but not
contralaterally (Fig. 2A, C). In adjacent sections treated with
TH antibody, TH-positive neurons were found in almost
equal numbers on both sides (Fig. 2B, D). On the ipsilateral
side, the ratio of FJC-positive cells to TH-positive cells was
approximately 1:5 (Fig. 2C, D).
Double labeling with FJC and TH showed that a few
FJC-positive neurons were immune-positive for TH. These
neurons were round and had shrunken cell bodies (Fig.
2E–J).
FJC staining in a chronic PD model
Previous studies from our laboratory have reported age-
dependent degeneration of the nigrostriatal DA neuron sys-
tem [22, 23]. In the present study, spatiotemporal changes in
the pattern of FJC-positive cells were examined in the stria-
tum and SN of zi/zi rats at time-points of 1M, 4M, and 12M.
At 1M, FJC-positive structures were barely observed in
either area in both zi/zi and control SD rats (Fig. 3A–D).
However, a few dot-shaped FJC-positive structures were
found in the striatum of zi/zi rats (Fig. 3C). At 4M, a large
number of FJC-positive structures, some of which were
linear and others dot-shaped, were found in the lateral
part of the striatum, whereas only a few FJC-positive struc-
tures were found in the SN, appearing larger than the dots
found in the striatum and seeming to represent shrunken cell
bodies without cellular processes (Fig. 3E, F). At 12M,
Fig. 1. Comparison of FJC staining between KA-treated samples (A
and C) and saline-treated control samples (B and D). FJC staining
in the cerebral cortex, layer V (A and B) and hippocampus, CA3 (C
and D). Bar=50 µm.
Table 1. Comparison of the intensity of FJC and immunofluores-
cence by different staining procedures
Note: Intensity of FJC or IF (NeuN): ++++, highest intensity; ++,
moderate intensity; +, low intensity; –, background intensity. FJC-IF,
FJC was followed by IF; FJC-NaBH4-IF, FJC was followed by sodium
borohydride and then IF; IF-FJC, IF was followed by FJC.
Protocol FJC-IF FJC-NaBH4-IF IF-FJC
FJC + + ++++
IF – + ++
Table 2. Comparison of time differences in photobleaching of FJC
and immunofluorescence stainings
Note: Intensity of FJC or IF (NeuN): ++++, highest intensity; +++,
high intensity; ++, moderate intensity; +, low intensity.
Time (min) 0 3 5 10
FJC ++++ ++++ ++++ ++++
IF +++ ++ ++ +
Table 3. Comparison of potassium permanganate-pretreatment
times in the intensity of FJC and immunofluorescence
Note: Intensity of FJC or IF (NeuN): ++++, highest intensity; +++,
high intensity; ++, moderate intensity; –; background intensity.
*The intensity of the FJC background was so high that the sample
showed a low stain-to-noise ratio.
Pretreatment 
time (min) 25 7 1 0
FJC *++++ +++ +++ ++
IF ++++ +++ ++ –Fluoro-Jade C in Neurodegeneration Models 175
FJC-positive dot-shaped structures were still observed
within the striatum and SN. However, these structures were
far fewer in number than at 4M, whereas very few FJC-
positive structures resembling cell bodies were detected in
the SN, as had been observed at 4M (Fig. 3G, H).
To determine the type of cells that labeled with FJC in
the SN and striatum, double labeling was performed for FJC
and TH or GFAP in the zi/zi rat brain at 4M, because con-
siderable FJC-labeling was found at this age. Dot-shaped
FJC-positive structures in the striatum were labeled with
TH (Fig. 4A–D). This meant that the dot-shaped co-labeling
structures were part of the fibers of DA neurons. In the SN,
FJC-positive cell bodies were weakly labeled or not labeled
with TH (Fig. 4E–H). In both areas, FJC-positive cells were
not double-labeled with GFAP (Fig. 4I–L).
Interestingly, small FJC-positive cells were also ob-
served within the hippocampal formation. So far, no reports
have described cell death in the hippocampal formation of
the zi/zi rat. We therefore tried to elucidate what types of
cells these were. The double-labeling study revealed that in
the hilus of the hippocampus, FJC-positive cells showed
small cell bodies with several short processes and were co-
localized with GFAP (Fig. 4M–P).
IV. Discussion
FJC is a novel fluorescent dye introduced in 2005 that
has been used to selectively stain degenerating neurons [20].
Compared with its predecessors, Fluoro-Jade and Fluoro-
Jade B, FJC exhibits the greatest signal-to-noise ratio, as
well as the highest resolution labeling not only of cell bodies
but also of dendrites, axons and terminals of degenerating
neurons. An additional feature of FJC is its compatibility
with several histological processing and staining protocols
such as 4'-6-diamidino-2-phenylindole staining, terminal
deoxynucleotidyl transferase-mediated dUTP nick-end la-
Fig. 2. Comparison of FJC staining (A and C) and TH immunostaining (B and D) between the contralateral side (A and B) and ipsilateral side
(C and D) in the SN at 3 days after intrastriatal 6-OHDA injection. High magnification view of the highlighted box in C (inset). Cell bodies of
the degenerating neurons induced by 6-OHDA were double labeled with IF using TH (E and H) and FJC (F and I) in the SNc and were round
(E–G) or shrunken (H–J). G and J represent mergers of E and F, and H and I respectively. SN, substantia nigra; SNc, substantia nigra pars
compacta; SNr, substantia nigra pars reticularis. Bars=100 µm (A–D) and 10 µm (inset in C and E–J).Ehara and Ueda 176
beling assay and IF [4, 20, 25]. Although studies have eval-
uated double labeling with FJC and IF, methods have varied
and technical problems have been encountered related to
procedures, photobleaching, and pretreatment, resulting
from susceptibilities of antigenic epitopes. Using the KA-
induced neuronal degeneration model, we therefore inves-
tigated these three issues and recommend the following
modifications of the double-labeling method: 1) IF should
be followed by FJC; 2) microscopy of double-labeled slides
should be performed within 5 min after photo-irradiation;
and 3) pretreatment time with potassium permanganate
should be shortened to 5 min rather than the 10 min used in
FJC single staining.
The acute neurodegeneration induced by 6-OHDA has
previously been detectable using Fluoro-Jade or Fluoro-
Jade B in the SN in the acute phase when the cell bodies
of affected TH-positive neurons have still been alive [21,
27]. Similarly, we found FJC-positive degenerating neu-
rons at 3 days after intrastriatal 6-OHDA injection. Although
Fluoro-Jade staining is confined to cell bodies [27], FJC
staining was located in both the processes and cell bodies,
indicating that FJC is more sensitive in detecting degenera-
tive processes than Fluoro-Jade in this model. Furthermore,
TH-positive neurons were similarly found on both the ipsi-
lateral and contralateral sides at 3 days after injection, but
some TH-positive neurons only on the ipsilateral side were
also stained with FJC (Fig. 3). It has been demonstrated that
intrastriatal 6-OHDA injection results in a partial progres-
sive loss of nigral TH-positive neurons with an onset at
about 1 week after injection; however, the cell death-related
factors Bcl-2, Bax, and caspase 3 have already changed the
level of mRNA or proteins in damaged DA neurons by 4
days after injection [9, 12]. Even though DA neurons still
show TH-immunoreactivity, the neurons may already be
damaged. TH-positivity in cells double labeled with FJC
may thus represent a sign of impending cell death.
Our results showed that FJC-positive neurons were
detected in zi/zi rats, in which a progressive neurodegenera-
tive process has been observed in the nigrostriatal system
[15, 22, 24]. The FJC-positive cell bodies were shrunken
and their fibers were swollen (Fig. 3). Such morphological
abnormalities in the zi/zi rat brain were also reported by
histological and electronmicroscopic studies [15, 22, 23].
Confirming these previous reports, FJC-positive fibers
were first found in the striatum of 1M zi/zi rats but not in
the SN, indicating that the death of DA neurons in the zi/zi
rats is preceded by a degeneration of DA terminals in the
Fig. 3
Fig. 3. In the SD rat, no FJC-positive neurons are seen in the stria-
tum (A) or SN (B) at 1M. Distribution of FJC-positive structures in
the striatum (C, E, and G) and SN (D, F, and H) of the zi/zi rat at
1M (C and D), 4M (E and F), and 12M (G and H). Staining shows
dot-shaped structures (white arrows), fiber-like structures (arrow-
heads) and cell body-like structures (yellow arrows). In the zi/zi rat,
high magnification views show the distinct shaped fibers stained by
FJC of the striatum at 1M (inset in C), 4M (inset in E), and 12M
(inset in G) and those of the SN at 4M (left-side inset in F), and the
cell bodies of the SN at 4M (right-side inset in F) and 12M (inset in
H). SN, substantia nigra; SNc, substantia nigra pars compacta; SNr,
substantia nigra pars reticularis. Bars=50 µm (A–H) and 10 µm
(inset in C and E–H).Fluoro-Jade C in Neurodegeneration Models 177
Fig. 4. Double labeling of FJC and IF using TH (A–H) or GFAP (I–P) in the striatum (A–D), SN (E–L), and hilus (M–P) of the zi/zi rat at 4M.
Each high magnification view of the structure (arrow) in A, E, I and M is shown in B–D, F–H, J–L and N–P; double labeling of FJC (B, F, J
and N) and IF using TH (C and G) or GFAP (K and O). D, H, L and P represent mergers of B and C, F and G, J and K, and N and O, respec-
tively. Bars=50 µm (A, E, I and M) and 10 µm (B–D, F–H, J–L and N–P).Ehara and Ueda 178
striatum. The number of FJC-positive neurons subsequently
increased until 4M, at which point TH-positive neurons
were reduced dramatically. At 12M, TH-positive neurons
were rare in the SN [23]. The present study demonstrates
that FJC is useful for detecting degenerating neurons in the
chronic neurodegeneration model. Contrasting with the
acute neurodegenerative model using 6-OHDA (Fig. 2),
we could not detect FJC-positive cells labeled with TH in
zi/zi rats at 4M (Fig. 4); at this age TH-positive cell loss
had already occurred [23]. In addition, FJC staining was
detected in damaged short processes of the neuronal cell
bodies in 6-OHDA-treated rats, but not in zi/zi rats. This
discrepancy may be attributable to the rate of accumulation
of the substance that binds to FJC in damaged neurons.
Although the intracellular molecules binding to FJC remain
obscure, candidate molecules would include those with
multiple positively charged groups such as poly-amines, as
all Fluoro-Jade dyes share the property of possessing multi-
ple acidic substitutions and are known as poly-anionic fluo-
rescein derivatives [20]. Acutely degenerating neurons may
accumulate these molecules faster than chronically degen-
erating neurons. Further studies are needed to determine the
biochemical properties of FJC.
Regarding the ability of FJC to label glial cells, our
double labeling study of the zi/zi rat hippocampus provides
new evidence. The present study showed that FJC and
GFAP were co-localized in the hilus, but not in the SN or
striatum (Fig. 4), indicating that specific substances interact-
ing with this anionic fluorescein derivative may exist in the
astrocytes in the zi/zi rat hippocampal formation and lead to
a change in homeostasis, which is a primary role of astro-
cytes. To date, studies using acute insult models have shown
that FJC-positive cells were not co-localized with GFAP
immunoreactivity [1, 3]. However, some authors have ob-
served FJC-positive cells exhibiting astroglial morphology
in the white matter or gray matter located near the ventricu-
lar and meningeal surfaces and the co-localization of FJC
and GFAP in some astrocytes of rat retinas [2, 4, 20]. Fur-
thermore, a recent study using a transgenic chronic model of
Alzheimer’s disease showed that Fluoro-Jade B labels acti-
vated astrocytes, which were identified as an increased in-
tensity of GFAP-immunoreaction [6]. In astrocytes, GFAP
upregulation is a central feature of astrogliosis after any pre-
ceding injury to the CNS [7]. Since the zi/zi rat is a sponta-
neous chronic neurodegenerative model and exhibits acti-
vated astrocytes [10], FJC may label glial cells in the zi/zi
brain. Although we cannot assert that FJC-positive astro-
cytes are dying, the cells may be damaged and show GFAP
upregulation with the resulting co-localization with GFAP in
the zi/zi rat. In the microglia, Fluoro-Jade B reportedly co-
localizes with a lysosomal membrane protein (CD68) within
the microglia or with amyloid-beta protein in glia-like cells,
and candidate molecules binding with Fluoro-Jade B could
thus exist in lysosomal vacuoles and/or in the core of amy-
loid deposits [6].
Under neurodegeneration, the differences in the mech-
anisms of degradation between astrocytes and neurons may
create differences in the accumulation rate of substances re-
acting to FJC. This may result in the difference between FJC
co-localizing with one cellular marker or another. We thus
cannot rule out the possibility that the substance that binds to
FJC may differ between stained astrocytes and stained
neurons.
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